Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

APOLLO HOSPITALS ENTERPRISE LTD.

NSE : APOLLOHOSPBSE : 508869ISIN CODE : INE437A01024Industry : Hospital & Healthcare ServicesHouse : Apollo Hospitals

BSE7088.35-13.45 (-0.19 %)

PREV CLOSE ( ) 7101.80

OPEN PRICE ( ) 7099.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 4561

TODAY'S LOW / HIGH ( )7015.15 7099.95

52 WK LOW / HIGH ( )6002.15 8099

NSE7086.50-14.5 (-0.2 %)

PREV CLOSE( ) 7101.00

OPEN PRICE ( ) 7075.00

BID PRICE (QTY) 7086.50 (6)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 205982

TODAY'S LOW / HIGH( ) 7015.50 7098.00

52 WK LOW / HIGH ( )6001 8099.5

Select year

(Rs.in Million)

Particulars

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Profit Before Tax

20314.00

13805.00

11005.00

15781.00

2215.00

Adjustment

11949.00

11992.00

11084.00

6814.00

10798.00

Changes In working Capital

-6039.00

-1928.00

-4500.00

-3592.00

-721.00

Cash Flow after changes in Working Capital

26224.00

23869.00

17589.00

19003.00

12292.00

Cash Flow from Operating Activities

21364.00

19202.00

13769.00

16960.00

12645.00

Cash Flow from Investing Activities

-33806.00

-15372.00

-8706.00

-8472.00

-8634.00

Cash Flow from Financing Activities

13168.00

-3111.00

-6330.00

-7916.00

-3401.00

Net Cash Inflow / Outflow

726.00

719.00

-1267.00

572.00

610.00

Opening Cash & Cash Equivalents

5055.00

4335.00

5463.00

3887.00

3807.00

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

1.00

Translation adjustment on reserves / op cash balalces frgn subsidiaries

1006.00

-165.00

Effect of Foreign Exchange Fluctuations

138.00

Closing Cash & Cash Equivalent

5781.00

5055.00

4334.00

5465.00

4252.00